Recall Enforment Report D-0720-2021
Recall Details
Drug Recall Enforcement Report Class II voluntary initiated by Eli Lilly & Company, originally initiated on 06-29-2021 for the product Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01 The product was recalled due to cgmp deviations: atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.. The product was distributed in Oh, Ms, In and the recall is currently terminated.
Recalled Products
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0002-4112 | Zyprexa | Olanzapine | Tablet | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4115 | Zyprexa | Olanzapine | Tablet | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4116 | Zyprexa | Olanzapine | Tablet | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4117 | Zyprexa | Olanzapine | Tablet | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4415 | Zyprexa | Olanzapine | Tablet | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4420 | Zyprexa | Olanzapine | Tablet | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4453 | Zyprexa Zydis | Olanzapine | Tablet, Orally Disintegrating | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4454 | Zyprexa Zydis | Olanzapine | Tablet, Orally Disintegrating | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4455 | Zyprexa Zydis | Olanzapine | Tablet, Orally Disintegrating | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-4456 | Zyprexa Zydis | Olanzapine | Tablet, Orally Disintegrating | Oral | Eli Lilly And Company | Human Prescription Drug |
0002-7597 | Zyprexa Intramuscular | Olanzapine | Injection, Powder, For Solution | Intramuscular | Eli Lilly And Company | Human Prescription Drug |